HK1030359A1 - Rapidly soluble drug composition comprising micronized as-3201. - Google Patents

Rapidly soluble drug composition comprising micronized as-3201.

Info

Publication number
HK1030359A1
HK1030359A1 HK01100617A HK01100617A HK1030359A1 HK 1030359 A1 HK1030359 A1 HK 1030359A1 HK 01100617 A HK01100617 A HK 01100617A HK 01100617 A HK01100617 A HK 01100617A HK 1030359 A1 HK1030359 A1 HK 1030359A1
Authority
HK
Hong Kong
Prior art keywords
micronized
drug composition
soluble drug
rapidly soluble
pharmaceutical composition
Prior art date
Application number
HK01100617A
Other languages
English (en)
Inventor
Mamoru Ohashi
Kazuyoshi Ogasawara
Yoshimi Shirai
Hiroshi Fujioka
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of HK1030359A1 publication Critical patent/HK1030359A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/499—Spiro-condensed pyrazines or piperazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK01100617A 1997-10-20 2001-01-29 Rapidly soluble drug composition comprising micronized as-3201. HK1030359A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30663597 1997-10-20
PCT/JP1998/004658 WO1999020277A1 (fr) 1997-10-20 1998-10-15 Composition medicamenteuse a dissolution rapide

Publications (1)

Publication Number Publication Date
HK1030359A1 true HK1030359A1 (en) 2001-05-04

Family

ID=17959478

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01100617A HK1030359A1 (en) 1997-10-20 2001-01-29 Rapidly soluble drug composition comprising micronized as-3201.

Country Status (22)

Country Link
US (2) US7141249B2 (de)
EP (1) EP1033132B1 (de)
KR (1) KR100571614B1 (de)
CN (1) CN1156277C (de)
AT (1) ATE296101T1 (de)
AU (1) AU740299B2 (de)
BR (1) BR9814090A (de)
CA (1) CA2306883C (de)
CZ (1) CZ299018B6 (de)
DE (1) DE69830333T2 (de)
ES (1) ES2242298T3 (de)
HK (1) HK1030359A1 (de)
HU (1) HUP0004132A3 (de)
ID (1) ID23915A (de)
NO (1) NO319049B1 (de)
NZ (1) NZ503796A (de)
PL (1) PL191533B1 (de)
PT (1) PT1033132E (de)
RU (1) RU2203665C2 (de)
TR (1) TR200001056T2 (de)
TW (1) TW592728B (de)
WO (1) WO1999020277A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1033132E (pt) * 1997-10-20 2005-09-30 Dainippon Pharmaceutical Co Composicao de farmaco rapidamente soluvel
EP1884242B1 (de) 2005-05-26 2013-04-17 Dainippon Sumitomo Pharma Co., Ltd. Pharmazeutische zusammensetzung enthaltend lurasidon
CA2733778A1 (en) * 2008-08-14 2010-02-18 Hiroshi Uchida Stabilized pharmaceutical composition
CN105769809A (zh) * 2014-12-23 2016-07-20 上海星泰医药科技有限公司 提高生物利用度的雷尼司他及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK607188A (da) * 1987-11-02 1989-06-22 Merck & Co Inc Tablet indeholdende en phthalazineddikesyreforbindelse
TW202450B (de) * 1991-06-26 1993-03-21 Dainippon Pharmaceutical Co
JPH0518672A (ja) * 1991-07-09 1993-01-26 Daido Steel Co Ltd 熱処理炉の冷却域における炉体構造
DE4141351A1 (de) * 1991-12-14 1993-06-17 Basf Ag Stabile pulverfoermige vitamin- und/oder carotinoid-praeparate und verfahren zu deren herstellung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US6458811B1 (en) * 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
ES2224436T3 (es) * 1997-10-20 2005-03-01 Dainippon Pharmaceutical Co., Ltd. Composicion estabilizada de la tetrahidropirrolo (1,2-a) pirazino-4-espiro-3'-pirrolidina.
PT1033132E (pt) * 1997-10-20 2005-09-30 Dainippon Pharmaceutical Co Composicao de farmaco rapidamente soluvel

Also Published As

Publication number Publication date
PL191533B1 (pl) 2006-06-30
US20020197308A1 (en) 2002-12-26
WO1999020277A1 (fr) 1999-04-29
KR100571614B1 (ko) 2006-04-17
CN1156277C (zh) 2004-07-07
US7141249B2 (en) 2006-11-28
ES2242298T3 (es) 2005-11-01
EP1033132B1 (de) 2005-05-25
CN1282246A (zh) 2001-01-31
CA2306883C (en) 2007-11-27
DE69830333D1 (de) 2005-06-30
NZ503796A (en) 2001-11-30
NO20002049D0 (no) 2000-04-18
CZ20001418A3 (cs) 2000-10-11
EP1033132A1 (de) 2000-09-06
CA2306883A1 (en) 1999-04-29
CZ299018B6 (cs) 2008-04-02
EP1033132A8 (de) 2001-04-04
TW592728B (en) 2004-06-21
HUP0004132A2 (hu) 2001-08-28
PT1033132E (pt) 2005-09-30
PL340045A1 (en) 2001-01-15
AU9461998A (en) 1999-05-10
NO319049B1 (no) 2005-06-06
ATE296101T1 (de) 2005-06-15
TR200001056T2 (tr) 2000-09-21
RU2203665C2 (ru) 2003-05-10
US20060269599A1 (en) 2006-11-30
AU740299B2 (en) 2001-11-01
ID23915A (id) 2000-05-25
NO20002049L (no) 2000-06-19
BR9814090A (pt) 2000-10-03
KR20010015781A (ko) 2001-02-26
DE69830333T2 (de) 2006-01-26
HUP0004132A3 (en) 2006-06-28

Similar Documents

Publication Publication Date Title
HK1049788A1 (en) Novel composition based on a thiazolidinedione andmetformin and use.
DE60045528D1 (de) Pharmazeutische zusammensetzungen, die ccr5-antagonisierende piperazinderivate enthalten
CA2288122A1 (en) Neuropeptide y receptor antagonist
BG104877A (en) N-substituted anminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
AU2001294606A1 (en) Substituted azepino(4,5b)indoline derivatives
CA2386690A1 (en) Pharmaceutical tramadol salts
AU7102201A (en) Propane-1,3-dione derivatives
WO2003037864A1 (fr) Compose indolique, et utilisation a des fins therapeutiques
EP2269608A3 (de) Pharmazeutische Zusammensetzungen welche Monoamin-Aufnahme-Neurotrransmitter-Reuptake-Inhibitoren und Acetylcholinesterase Inhibitoren enthalten
CA2347195A1 (en) Oral pharmaceutical compositions containing buprenorphin
CA2386813A1 (en) Bicyclic imidazo-3-yl amine derivatives substituted on the 6-membered ring
CA2338794A1 (en) New oral formulation for 5-ht4 agonists or antagonists
WO2002067865A3 (en) N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
EP0670166A3 (de) Oral verabreichbare Arzneimittel.
HK1030359A1 (en) Rapidly soluble drug composition comprising micronized as-3201.
CA2027814A1 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
AU674379B2 (en) Antitussive
AU9270598A (en) Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
WO2001004112A3 (de) Benzofuranderivate
CA2340427A1 (en) Non-sedating diphenhydramine metabolites
CA2349452A1 (en) Therapeutic agents for drug dependence
WO2001046178A3 (en) Substituierte bisindolymaleimide
CA2290557A1 (en) Use of 4-substituted tetrahydropyridines for making medicines acting on tgf-.beta.1
CA2292017A1 (en) Substituted cycloheptenes, their preparation and use

Legal Events

Date Code Title Description
CHPA Change of a particular in the register (except of change of ownership)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20141015